• Topic 1: Discuss the production process of your company’s vaccine, how it was tested in the pre-clinical setting and key favorable results that facilitated clinical development.
• Topic 2: Detail the immune response elicited after immunization with your company’s vaccine and provide some insight into how your company’s sublingual product may be able to protect against infection as well as disease.
• Topic 3: Describe the clinical trials your company has been through thus far with the vaccine including the three major players involved in the process. Outline the key data that will be gathered during the phase 3 trial and how it will be used to advance the product. Detail why you are conducting the phase 3 trial in a developing country (Kenya) and the ethical or non-ethical ramifications your company conducting the trial overseas.
• Topic 4: Vaccines come with inherent risks and poliovirus vaccines have had several past instances of significant risks. Describe the past issues with poliovirus vaccine production and immunization and how your vaccine will be able to avoid those issues.